Impact of BRCA in patientsundergoingabirateronestereotacticbody radiotherapy: the ARTO trial. Francolini G, Di Cataldo V, Garlatti P, Bertini N, Aquilano M, Caini S, Ingrosso G, Bruni A, D’Angelillo RM, Tagliaferri L, Augugliaro M, Triggiani L, Parisi S, Simontacchi G, Jereczek-Fossa BA, Marvaso G, Alongi F, Arcidiacono F, Lancia A, Scorsetti M, Desideri I, Meattini I, Mangoni M, Masieri L, Livi L; ARTO working group members. BJU Int. 2025 Dec 15. doi: 10.1111/bju.70070. Online ahead of print.
Recommendationsfor radiotherapyin patientswith lungcancerand interstitiallungdisease: A Delphi consensus processof the Italianassociationof radiotherapyand clinical oncology(AIRO). Borghetti P, D’Angelillo R, Facheris G, Borghesi A, Bruni A, Ceruti P, Ferrari K, Filippi AR, Ramella S, Signorelli D, Pappagallo G, Ricardi U; Collaborators. Lung Cancer. 2025 Dec;210:108807. doi: 10.1016/j.lungcan.2025.108807. Epub 2025 Nov 3.
Clinical Outcomesand PredictiveFactorsin NSCLC after Surgery: Findingsfrom the RAC-TAC Study. Bruni A, Franceschini D, Marini B, Vagge S, Ciammella P, Sepulcri M, Grassi R, Gagliardi F, Cappelli A, D’Angelo E, Manetta M, Scricciolo M, Guida C, Fazio I, Borghetti P, Cappabianca S, Nardone V. Clin Lung Cancer. 2025 Sep 30:S1525-7304(25)00237-2. doi: 10.1016/j.cllc.2025.09.012. Online ahead of print.
LocallyadvancedNSCLC: overviewof real-world pattern of recurrencein durvalumabera (LEOPARD trial). Ciammella P, Iori F, Borghetti P, Galaverni M, Alì E, Tiseo M, Pagano M, Sepulcri M, Scotti V, GiajLevra N, Marcenaro M, Simoni N, Nardone V, Botti A, Cozzi S, Bruni A. Lung Cancer. 2025 Sep;207:108718. doi: 10.1016/j.lungcan.2025.108718. Epub 2025 Aug 22.
PREDICTIVE BRCA GENETIC TESTING IN ITALIAN PATIENTS WITH BREAST CANCER: A POSITION PAPER OF ITALIAN SCIENTIFIC SOCIETIES [ItalianAssociation of MedicalOncology(AIOM); ItalianAssociation of Radiotherapyand Clinical Oncology(AIRO); ItalianNational Association of BreastSurgeons(ANISC); ItalianSociety of PathologicalAnatomyand DiagnosticCytology(SIAPeC-IAP); ItalianSociety of SurgicalOncology(SICO); ItalianSociety of Human Genetic(SIGU); ItalianSociety of General Practice (SIMG); ItalianSociety of Medicaland InterventionalRadiology(SIRM)]. Cortesi L, Miglietta F, Arecco L, Bernardi D, Biganzoli L, Del Mastro L, Dieci MV, Foglietta J, Fortunato L, Franco P, Cordisco EL, Mantellini P, Marchio’ C, Meduri B, Micallo G, Musolino A, Salvetti A, Turchetti D, Zambelli A, Angiolini C, Cinieri S, Conte PF, Curigliano G, Dessena M, Fabi A, Leonardi MC, Meattini I, Montemezzi S, Puglisi F, Sapino A, Taffurelli M, Cinquini M, Gori S. Cancer Treat Rev. 2025 Sep;139:102976. doi: 10.1016/j.ctrv.2025.102976. Epub 2025 Jun 15.
Dose-intensifiedSBRT for vertebraloligometastases: resultsfrom a prospectiveclinical trial. Guckenberger M, Wilke L, Billiet C, Rogers S, Franzese C, Schnell D, Spałek M, Aebersold DM, Hemmatazad H, Zilli T, Boda-Heggemann J, Baumert BG, Stelmes JJ, Nägler F, Gut P, Weiß C, Bruni A, Zimmermann F, Förster R, Zimmer J, Madani I. Radiother Oncol. 2025 Jul;208:110940.doi:10.1016/j.radonc.2025.110940. Epub 2025 May 14.
Hypofractionatedradiotherapyin elderlypatients(75 years) affectedby localizedprostate cancer: a multicenterretrospectiveanalysisfrom the IPOPROMISE study. Ingrosso G, Festa E, Caini S, Ponti E, Francolini G, Doccioli C, Lancia A, Fondelli S, Santini R, Valeriani M, Rago L, Bruni A, Augurio A, Trippa F, Russo D, Tamburo M, Parisi S, Borghesi S, Gomellini S, Scoccianti S, Musio D, Stefanacci M, Facondo G, Statuto T, Miranda G, Santo B, Di Marzo A, Bellavita R, Vinciguerra A, Livi L, Aristei C, Detti B. Prostate Cancer Prostatic Dis. 2025 Dec;28(4):938-945. doi: 10.1038/s41391-025-00962-z. Epub 2025 Mar 17.
Real-World Insights intothe Impact of Durvalumabon Stage III UnresectableNon-Small Cell LungCancer-A Narrative Review. Facheris G, Cossali G, Imbrescia J, La Mattina S, Mataj E, Meli N, Volpi G, Triggiani L, Guerini AE, Levi G, Grisanti S, Buglione di Monale E Bastia M, Borghetti P. Cancers (Basel). 2025 Mar 3;17(5):874. doi: 10.3390/ cancers17050874.
Impact of stereotacticbody radiotherapyafter progressionin castrate resistantprostate cancerpatientsundergoingfirst line abirateronetreatment. A subgroupanalysisfrom ARTO trial (NCT03449719). Francolini G, Bertini N, Di Cataldo V, Garlatti P, Aquilano M, Caini S, Bruni A, Ingrosso G, D’angelillo RM, Tagliaferri L, Augugliaro M, Triggiani L, Parisi S, Timon G, Arcidiacono F, Marvaso G, Jereczek-Fossa BA, Lancia A, Franzese C, Alongi F, Simontacchi G, Greto D, Bonomo P, Loi M, Frosini G, Burchini L, Desideri I, Meattini I, Valicenti RK, Livi L. Prostate Cancer Prostatic Dis. 2025 Dec;28(4):908-912. doi: 10.1038/s41391-025-00950-3. Epub 2025 Feb
Single-modalityendocrine therapy versus radiotherapyafter breast-conservingsurgery in women aged70 yearsand olderwith luminal A-like earlybreastcancer(EUROPA): a preplannedinterim analysisof a phase3, non-inferiority, randomisedtrial. Meattini I, De Santis MC, Visani L, Scorsetti M, Fozza A, Meduri B, De Rose F, Bonzano E, Prisco A, Masiello V, La Rocca E, Spoto R, Becherini C, Blandino G, Moscetti L, Colciago RR, Audisio RA, Brain E, Caini S, Hamaker M, Kaidar-Person O, Lambertini M, Marrazzo L, Saieva C, Spanic T, Strnad V, Wheelwright S, Poortmans PMP, Livi L; EUROPA Trial Investigators. Lancet Oncol. 2025 Jan;26(1):37-50. doi: 10.1016/S1470-2045(24)0 61-2. Epub 2024 Dec 12.